Mitomycin C, vinblastine and carboplatin: Effective outpatient chemotherapy for advanced non-small cell carcinoma of thelung (NSCLC)

Clinical Oncology

Volumn 13, Issue 6, 2001, Pages 483-487

  Gregory, R K ^a   Smith, I E ^a   Norton, A ^a   Ashley, S ^a   O'Brien, M E R ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Carboplatin; Chemotherapy; Non small cell lung cancer; Outpatient treatment

Indexed keywords

CARBOPLATIN; CISPLATIN; DEXAMETHASONE; GRANISETRON; METOCLOPRAMIDE; MITOMYCIN C; PLATINUM DERIVATIVE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ECONOMIC ASPECT; FEMALE; HOSPITALIZATION; HUMAN; HYDRATION; LUNG NON SMALL CELL CANCER; MALE; OUTPATIENT CARE; PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SYMPTOM; VOMITING;

EID: 0035685736     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2001.9320     Document Type: Article

References (13)

1. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised trials
2. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer
3. Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors
4. Randomised comparison of two combination regimens versus minimal chemotherapy in non small cell lung cancer
5. Chemotherapy of advanced non-small cell lung cancer with cyclophosphamide, adriamycin, methotrexate and procarbazine versus cisplatin and etoposide: A randomised study
6. Randomised study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
7. Symptom relief with moderate dose chemotherapy (mitomycin C, vinblastine and cisplatin) in advanced non-small cell lung cancer
8. Cisplatin or carboplatin for ovarian and testicular cancer?
9. Mitomycin C, vinblastine, and carboplatin regimen in patients with non-small cell lung cancer
10. Duration of chemotherapy for advanced NSCLC: A Phase III randomised trial of 3 versus 6 courses of mitomycin C, vinblastine and cisplatin
11. Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: Treatment good enough to compare
12. A randomised trial of two platinum combinations in patients with advanced non-small cell lung cancer: A preliminary report
13. Prognostic analysis of survival in the European randomised trial comparing navelbine vs navelbine cisplatin vs vindesine cisplatin